These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
þ
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
LASERLOCK TECHNOLOGIES, INC.
|
|
Nevada
|
23-3023677
|
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
(IRS Employer
Identification No.)
|
|
837 Lindy Lane
Bala Cynwyd, PA 19004
|
||
|
(Address of Principal Executive Offices) (Zip Code)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
þ
|
|
Page
|
||
|
PART I
|
||
|
1
|
||
|
9
|
||
|
9
|
||
|
9
|
||
|
9
|
||
|
9
|
||
|
PART II
|
||
|
10
|
||
|
12
|
||
|
12
|
||
|
18
|
||
|
18
|
||
|
18
|
||
|
19
|
||
|
19
|
||
|
PART III
|
||
|
20
|
||
|
25
|
||
|
26
|
||
|
28
|
||
|
28
|
||
|
PART IV
|
||
|
30
|
|
1.
|
Optical technologies - use of light, i.e. holograms;
|
|
2.
|
Electronic - magnetic strips and smart cards;
|
|
3.
|
Biotechnologies - uses
characteristics of biological proteins such as antibodies, enzymes and DNA; and
|
|
4.
|
Chemical technologies -
include photochromic (light-reactive) and thermochromic (heat-reactive) inks.
|
|
1.
|
Documents of Value
|
|
a.
|
Currency,
|
|
b.
|
Stock certificates and bonds,
|
|
c.
|
Event tickets, and
|
|
d.
|
Lottery tickets.
|
|
2.
|
Homeland Security
|
|
a.
|
Container seals,
|
|
b.
|
Pallet security,
|
|
c.
|
Passports,
|
|
d.
|
ID cards,
|
|
e.
|
Driver licenses, and
|
|
f.
|
Visas.
|
|
3.
|
Consumer Product Security
|
|
a.
|
Tax stamps,
|
|
b.
|
CDs/DVDs,
|
|
c.
|
Apparel tags and labels,
|
|
d.
|
Pharmaceuticals,
|
|
e.
|
Tobacco,
|
|
f.
|
Alcohol,
|
|
g.
|
Auto parts,
|
|
h.
|
Aviation parts, and
|
|
i.
|
Any other packaging requirements.
|
|
4.
|
Gaming
|
|
a.
|
Chips,
|
|
b.
|
Dice,
|
|
c.
|
Playing cards,
|
|
d.
|
E-proms/critical memory devices, and
|
|
e.
|
Slot tickets.
|
|
5.
|
Product Diversion Tracking
|
|
a.
|
Fragrances,
|
|
b.
|
Apparel/licensed merchandise,
|
|
c.
|
Cosmetics,
|
|
d.
|
Pharmaceuticals, and
|
|
e.
|
Watches and jewelry.
|
|
6.
|
Financial Services and Products
|
|
a.
|
Credit cards,
|
|
b.
|
Bank checks, and
|
|
c.
|
Financial documents/promissory notes.
|
|
1.
|
Security Ink Manufacturers. These are generally well-established companies such as SICPA and Sun Chemical, whose core business is printing inks;
|
|
2.
|
System Integrators. These companies have often evolved from other sectors in the printing industry, mainly security printing manufacturers, technology providers, or packaging and label manufacturers. These companies offer a range of security solutions, enabling them to provide a complete suite of solutions tailored to the customer’s specific needs and requirements. The companies in this space include 3M, DuPont, Honeywell, and Avery Dennison;
|
|
3.
|
System Consultancy Groups. These companies offer a range of technologies from several different providers and tailor specific solutions to end-users;
|
|
4.
|
Traditional Authentication Technology Providers. These purveyors include American Banknote Holographics, and Digimarc, which provide holograms and digital watermarking, respectively;
|
|
5.
|
Product Diversion Tracking Providers. Next-Generation Technology Providers LLC falls into this group, along with several companies such as Authentix, DNA Technologies, and Identif, which provide on-product and in-product tagging technologies; and
|
|
6.
|
Traditional Security Printers. Traditional security printers such as Thomas de la Rue and Portals whose core products are printing the world’s currencies.
|
|
Fiscal Year Ended December 31, 2012
|
High
|
Low
|
|
Quarter ended March 31, 2012
|
$0.07
|
$0.01
|
|
Quarter ended June 30, 2012
|
$0.07
|
$0.05
|
|
Quarter ended September 30, 2012
|
$0.06
|
$0.02
|
|
Quarter ended December 31, 2012
|
$0.05
|
$0.02
|
|
Fiscal Year Ended December 31, 2011
|
High
|
Low
|
|
Quarter ended March 31, 2011
|
$0.01
|
$0.005
|
|
Quarter ended June 30, 2011
|
$0.05
|
$0.0075
|
|
Quarter ended September 30, 2011
|
$0.07
|
$0.025
|
|
Quarter ended December 31, 2011
|
$0.16
|
$.0299
|
|
Plan Category
|
Number of
securities
to be
issued
upon
exercise of
outstanding
options,
warrants
and rights
(a)
|
Weighted-
average
exercise
price of
outstanding
options,
warrants and
rights
(b)
|
Number of
securities
remaining
available
for future
issuance
under
equity
compensation
plans
(excluding
securities
reflected in
column (a))
(c)
|
|||||||||
|
Equity compensation plans approved by security holders
|
2,435,000 | $ |
.00
|
1,074,004
|
||||||||
|
Equity compensation plans not approved by security holders
|
12,900,000
|
$ |
.05
|
-
|
|
|||||||
|
Total:
|
15,335,000 |
|
$ |
.05
|
1,074,004
|
|||||||
|
|
(a)
|
$450,000 on the date of the agreement (December 31, 2012), consisting of $250,000 in cash and warrants to purchase 4,444,444 shares of common stock under a cashless exercise initially at an exercise price of $0.045 on the terms set forth under the warrants issued by the Company to Zaah, dated as of December 31, 2012,
|
|
|
(b)
|
$100,000, accrued in full as of the date of the agreement, but payable in twelve (12) months from the date hereof to a designee of Zaah
’s
selection, with a right to convert (at Zaah’s sole discretion, from time to time at any time) to shares of common stock at the prevailing market price per share of common stock (which, as long as the common stock is listed, shall be the closing price on the last trading day prior to such issuance or sale of the common stock as traded on a national securities exchange, the NASDAQ Global Market, the NASDAQ Capital Market, or another nationally recognized trading system (including Pink OTC Markets, Inc.)), and
|
|
|
(c)
|
a commission of 10% of the revenue generated by any Company transaction originated through the efforts of Zaah, as substantiated by a written agreement between the Company and Zaah, specifically referencing the transaction in which Zaah is entitled to such commission, payable by the Company to Zaah in cash. Such payment shall be made on the earlier of (i) the date of the signing of such transaction, (ii) the date of the closing of such transaction, or (iii) any date on which any funds are paid to the Company in respect to such transaction.
|
|
|
(a)
|
Payment 1, payable upon execution of the agreement on December 31, 2012: The sum of One Hundred Thousand Dollars ($100,000), to be paid by issuing (i) a number of shares of common stock, of the Company equal to (x) $100,000 divided by (y) $0.045 (2,222,222 shares) and (ii) cashless exercise warrants to purchase an equal number of shares exercisable at a price of Ten Cents ($0.10) per share with a term of five (5) years.
|
|
|
(b)
|
Payment 2, payable on January 1, 2014: The sum of Four Hundred Thousand Dollars ($400,000), to be paid by issuing (i) a number of shares equal to (x) $400,000 divided by (y) a price which equals a 10% discount to market and (ii) cashless exercise warrants to purchase an equal number of shares exercisable at a price of Ten Cents ($0.10) per share with a term of five (5) years.
|
|
|
(c)
|
Payment 3, payable on January 1, 2015: The sum of Four Million Five Hundred Thousand Dollars ($4,500,000), to be paid by issuing (i) a number of shares equal to (x) $4,500,000 divided by (y) a price which equals a 10% discount to market and (ii) cashless exercise warrants to purchase an equal number of shares exercisable at a price of Ten Cents ($0.10) per share with a term of five (5) years.
|
|
|
(d)
|
Future Payments Contingent: The Company’s payment of Payment 2 and Payment 3 is contingent. To the extent that VerifyMe does not develop and license to the Company at a time subsequent to Payment 1, further technology and/or a further patent right related to the local, mobile and cloud based biometric security systems, then any payments not already paid, will not longer be due to VerifyMe, this nonperformance being a likelihood, more likely than not.
|
|
Name
|
Age
|
Position with Company
|
||||
|
Michael R. Sonnenreich
|
74
|
Chairman of the Board of Directors
|
||||
|
Norman A. Gardner
|
70
|
Vice Chairman of the Board of Directors and Chief Executive Officer
|
||||
|
Neil Alpert
|
35
|
Director, President and Chief Operating Officer
|
||||
|
Constance Harriman
|
64
|
Director
|
||||
|
General Peter Pace
|
67
|
Director
|
||||
|
Paul Wolfowitz
|
68
|
Director
|
||||
|
Jonathan Weinberger
|
36
|
Director
|
||||
|
Claudio R. Ballard
|
54
|
Director
|
||||
| Scott A. McPherson | 51 | Chief Financial Officer | ||||
|
Name and Principal
Position
|
Year
|
Salary
($)
|
Option
Awards(1)
($)
|
All Other
Compensation
(3)(4)($)
|
Total
($)
|
|
Norman A. Gardner (2)
Vice Chairman & CEO
|
2012
2011
|
50,000
180,000
|
44,769
40,946
|
56,414
35,880
|
151,183
256,826
|
|
Neil Alpert
President & COO
|
2012
2011
|
50,000
-
|
44,769
-
|
-
-
|
94,769
-
|
|
Scott A. McPherson
CFO |
2012
2011
|
-
-
|
11,638
-
|
16,325
19,500
|
27,963
19,500
|
|
(1)
|
Represents the grant date fair value of the option award, calculated in accordance with FASB Accounting Standard Codification 718, “Compensation – Stock Compensation,
”
or ASC 718. The assumptions used in calculating the grant date fair value of the option awards are set forth in Note 9 of our Consolidated Financial Statements.
|
|
(2)
|
Mr. Gardner was appointed as our President and Chief Executive Officer on November 10, 1999. The $180,000 of salary in 2011 was forgiven in 2012 by Mr. Gardner.
|
|
(3)
|
Company car, insurance, occupancy costs and expenses.
|
|
(4)
|
Mr. McPherson was appointed as Chief Financial Officer in December 2012 and the amounts received were paid to the accounting firm owned by Mr. McPherson.
|
|
Name
|
Number of
securities
underlying
unexercised options
(#)
exercisable
|
Number of
securities
underlying
unexercised options
(#)
unexercisable
|
Option exercise
price
($)
|
Option expiration
Date
|
|
Norman A. Gardner
|
1,000,000
|
-
|
$0.05
|
11/20/2022
|
|
Neil Alpert
|
1,000,000
|
-
|
$0.05
|
11/20/2022
|
|
Scott A. McPherson
|
200,000
|
-
|
$0.05
|
7/16/2022
|
|
Name
|
Fees earned or paid
in cash
($)
|
Option awards
($)(1)
|
Total
($)
|
|||||
|
Michael Sonnenreich
|
2012
2011
|
-
-
|
89,568
-
|
89,568
-
|
||||
|
Neil Alpert
|
2012
2011
|
-
-
|
-
-
|
-
-
|
||||
|
Constance Harriman
|
2012
2011
|
-
-
|
89,568
-
|
89,568
-
|
||||
|
General Peter Pace
|
2012
2011
|
-
-
|
89,568
-
|
89,568
-
|
||||
|
Paul Wolfowitz
|
2012
2011
|
-
-
|
89,568
-
|
89,568
-
|
||||
|
Jonathan Weinberger (2)
|
2012
2011
|
-
-
|
89,568
-
|
89,568
-
|
|
(1)
|
Represents the grant date fair value of the option award, calculated in accordance with FASB Accounting Standard Codification 718, “Compensation – Stock Compensation,“ or ASC 718. The assumptions used in calculating the grant date fair value of the option awards are set forth in Note 9 of our Consolidated Financial Statements.
|
|
(2)
|
VerifyMe, Inc. controls these options.
|
|
Name and Address of Beneficial Owner
|
Amount and Nature
Of Beneficial
Ownership(1)
|
Percentage of Class
|
||
|
5% Beneficial Owners
|
||||
|
Robert L. Bast
110 Spruce Lane
Ambler, PA 19002
|
28,423,622(2)
|
7.25%
|
||
|
California Securities SA
60 West Randolph Street, Suite 200
Chicago, IL 60601
|
16,986,595(3)
|
4.33%
|
||
|
Clydesdale Partners II LLC
201 Spear Street, Suite 1150
San Francisco, CA 94105
|
45,875,000(4)
|
11.70%
|
||
|
Nob Hill Capital Partners L.P.
1 Ferry Building, Suite 225
San Francisco, CA 19411
|
32,250,000(5)
|
8.22%
|
||
|
VerifyMe, Inc.
205 Linda Drive
Daingerfield, TX 75638
|
155,333,332(6)
|
39.60%
|
||
|
Executive Officers and Directors
|
||||
|
Michael R. Sonnenreich
|
5,000,000(7)
|
1.27%
|
||
|
Norman A. Gardner
|
17,421,339(8)
|
4.44%
|
||
|
Neil Alpert
|
1,000,000(9)
|
*
|
||
|
Constance Harriman
|
3,000,000(10)
|
*
|
||
|
General Peter Pace
|
1,000,000(11)
|
*
|
||
|
Paul Wolfowitz
|
1,000,000(12)
|
*
|
||
|
Jonathan Weinberger
|
1,000,000(13)
|
*
|
||
|
Claudio R. Ballard
|
1,000,000(14)
|
*
|
||
|
Scott A. McPherson
|
200,000(15)
|
*
|
||
|
All officers and directors as a group (9 people)
|
30,621,339
|
7.81% |
| 3.1 |
Amended and Restated Articles of Incorporation of the Company dated December 17, 2003 (filed as an exhibit to the Company’s Annual Report on Form 10-KSB filed with the Securities and Exchange Commission on March 30, 2004 and incorporated herein by reference).
|
| 3.2** |
Certificate of Amendment to Amended and Restated Articles of Incorporation of LaserLock Technologies, Inc., dated as of November 29, 2012 (filed herewith).
|
| 3.3 | Amended Certificate of Designation of Series A Preferred Stock, dated as of January 31, 2013 (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 6, 2013 and incorporated herein by reference). |
| 3.4 | Amended and Restated Bylaws of the Company dated December 17, 2003 (filed as an exhibit to the Company’s Annual Report on Form 10-KSB filed with the Securities and Exchange Commission on March 30, 2004 and incorporated herein by reference). |
| 10.1 |
Employment Agreement by and between the Company and Norman Gardner dated November 5, 2003 (filed as an exhibit to the Company’s Annual Report on Form 10-KSB filed with the Securities and Exchange Commission on March 30, 2004 and incorporated herein by reference).
|
| 10.2 |
Stock Loan Agreement by and among Norman Gardner, Californian Securities, SA and Pacific Continental Securities (UK) Nominees Limited and the Company (filed as an exhibit to the Company’s Quarterly Report on Form 10-QSB filed with the Securities and Exchange Commission on November 14, 2003 and incorporated herein by reference).
|
| 10.3 |
Regulation S Stock Purchase Agreement, dated May 2, 2003, by and between the Company and Californian Securities, S.A. (filed as an exhibit to the Company’s Quarterly Report on Form 10-QSB filed with the Securities and Exchange Commission on August 14, 2003 and incorporated herein by reference).
|
| 10.4 |
Amendment to Regulation S Stock Purchase Agreement by and between the Company and Californian Securities, S.A., dated October 15, 2003 (filed as an exhibit to the Company’s Quarterly Report on Form 10-QSB filed with the Securities and Exchange Commission on November 14, 2003 and incorporated herein by reference).
|
| 10.5 |
Regulations S Stock Purchase Agreement, dated March 10, 2004, by and between the Company and California Securities, S.A. (filed as an exhibit to the Company’s Quarterly Report on Form 10-QSB filed with the Securities and Exchange Commission on May 17, 2004 and incorporated herein by reference).
|
| 10.6 |
Senior Secured Convertible Note and Warrant Purchase Agreement, dated February 13, 2006, among the Company and Nob Hill Capital Partners, L.P. (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 17, 2006 and incorporated herein by reference).
|
| 10.7 |
Schedule of Purchasers who have entered into the Senior Secured Convertible Note and Warrant Purchase Agreement (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 17, 2006 and incorporated herein by reference).
|
| 10.8 |
Senior Secured Convertible Promissory Note, dated February 17, 2006, by the Company in favor of Nob Hill Capital Partners, L.P. in the amount of $100,000 (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 17, 2006 and incorporated herein by reference).
|
| 10.9 |
Schedule of Payees who have entered into a senior secured convertible promissory note substantially identical to the Senior Secured Convertible Promissory Note (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 17, 2006 and incorporated herein by reference).
|
| 10.10 |
Warrant, issued by the Company in favor of Nob Hill Capital Partners, L.P., dated February 13, 2006 (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 17, 2006 and incorporated herein by reference).
|
| 10.11 |
Schedule of Holders to whom the Company has issued a warrant substantially identical to the Warrant (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 17, 2006 and incorporated herein by reference).
|
| 10.12 |
Security Agreement, dated February 13, 2006, by and between the Company and Nob Hill Capital Partners, L.P. (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 17, 2006 and incorporated herein by reference).
|
| 10.13 |
Schedule of Secured Parties who have entered into a security agreement substantially identical to the Security Agreement (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 17, 2006 and incorporated herein by reference).
|
| 10.14 |
Grant of 3,000,000 shares of the Company to Norman A. Gardner on January 3, 2006 in consideration for services provided to the Company (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 18, 2006 and incorporated herein by reference).
|
| 10.15 |
LaserLock Technologies, Inc. 2003 Stock Option Plan adopted on December 19, 2003 (filed as an exhibit to the Company’s Annual Report on Form 10-KSB filed with the Securities and Exchange Commission on March 30, 2004 and incorporated herein by reference).
|
| 10.16 |
Option Agreement, dated as of March 23, 2012, between the Company and Gaming Partners International Corporation (filed as an exhibit to the Company
’
s Annual Report on Form 10-K filed with the Securities and Exchange Commission on July 13, 2012 and incorporated herein by reference).
|
|
10.17**
|
Investment Agreement, dated as of December 31, 2012, between LaserLock Technologies, Inc. and VerifyMe, Inc. (filed herewith).
|
|
10.18**
|
Registration Rights Agreement, dated as of December 31, 2012, between LaserLock Technologies, Inc. and VerifyMe, Inc. (filed herewith).
|
|
10.19**
|
Technology and Services Agreement, dated as of December 31, 2012, between LaserLock Technologies, Inc. and VerifyMe, Inc. (filed herewith).
|
|
10.20**
|
Patent and Technology License Agreement, dated as of December 31, 2012, between LaserLock Technologies, Inc. and VerifyMe, Inc. (filed herewith).
|
|
10.21**
|
Asset Purchase Agreement, dated as of December 31, 2012, between LaserLock Technologies, Inc. and VerifyMe, Inc. (filed herewith).
|
|
10.22**
|
Technology and Services Agreement (Zaah), dated as of December 31, 2012, between LaserLock Technologies, Inc. and Zaah Technologies, Inc. (filed herewith).
|
| 10.23** | Employment Agreement between LaserLock Technologies, Inc. and Norman Gardner, dated as of October 8, 2012 (filed herewith). |
| 10.24** | Employment Agreement between LaserLock Technologies, Inc. and Neil Alpert, dated as of October 8, 2012 (filed herewith). |
| 10.25** | Employment Agreement between LaserLock Technologies, Inc. and Scott McPherson, dated as of December 14, 2012 (filed herewith). |
| 10.26** | Nonqualified Stock Option Grant Agreement between LaserLock Technologies, Inc. and Norman Gardner, dated as of November 21, 2012 (filed herewith). |
| 10.27 | Nonqualified Stock Option Grant Agreement between LaserLock Technologies, Inc. and Neil Alpert, dated as of November 21, 2012 (option grant on identical terms and for same amount of options as pursuant to agreement filed as Exhibit 10.26). |
| 10.28** | Nonqualified Stock Option Grant Agreement between LaserLock Technologies, Inc. and Michael Sonnenreich, dated as of November 21, 2012 (filed herewith). |
| 10.29 | Nonqualified Stock Option Grant Agreement between LaserLock Technologies, Inc. and Constance Harriman, dated as of November 21, 2012 (option grant on identical terms and for same amount of options as pursuant to agreement filed as Exhibit 10.28). |
| 10.30 | Nonqualified Stock Option Grant Agreement between LaserLock Technologies, Inc. and Peter Pace, dated as of November 21, 2012 (option grant on identical terms and for same amount of options as pursuant to agreement filed as Exhibit 10.28). |
| 10.31 | Nonqualified Stock Option Grant Agreement between LaserLock Technologies, Inc. and Jonathan Weinberger, dated as of November 21, 2012 (option grant on identical terms and for same amount of options as pursuant to agreement filed as Exhibit 10.28). |
| 10.32 | Nonqualified Stock Option Grant Agreement between LaserLock Technologies, Inc. and Paul Wolfowitz, dated as of November 21, 2012 (option grant on identical terms and for same amount of options as pursuant to agreement filed as Exhibit 10.28). |
| 10.33 | Subscription Agreement between LaserLock Technologies, Inc. and VerifyMe, Inc., dated as of January 31, 2013 (filed as an exhibit to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 6, 2013 and incorporated herein by reference). |
|
14.1**
|
Code of Ethics (filed herewith).
|
| 23.1** |
Consent of Morison Cogen LLP (filed herewith).
|
|
31.1
**
|
Certification of the principal executive officer of the Company, pursuant to Securities Exchange Act Rule 13a-14(a)
|
|
31.2
**
|
Certification of the principal financial officer of the Company, pursuant to Securities Exchange Act Rule 13a-14(a)
|
|
32.1
**
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, signed by the chief executive officer of the Company
|
|
32.2
**
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, signed by the chief financial officer of the Company
|
|
101.INS**
|
XBRL Instance Document
|
|
101.SCH**
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL**
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF**
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB**
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE**
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
LaserLock Technologies, Inc.
|
|||
|
By:
|
/s/ Norman A. Gardner
|
||
|
Norman A. Gardner
,
Vice Chairman of the Board and Chief Executive Officer
|
|||
|
Signature
|
Title
|
Date
|
||
| /s/ Michael R. Sonnenreich |
Chairman of the Board
|
April 1, 2013
|
||
| Michael R. Sonnenreich |
|
Signature
|
Title
|
Date
|
||
|
/s/ Norman A. Gardner
|
Vice Chairman of the Board and Chief Executive Officer
|
April 1, 2013
|
||
| Norman A. Gardner |
|
Signature
|
Title
|
Date
|
||
|
/s/ Neil Alpert
|
President, Chief Operating Officer and Director
|
April 1, 2013
|
||
| Neil Alpert |
|
Signature
|
Title
|
Date
|
||
| /s/ Constance Harriman |
Director
|
April 1, 2013
|
||
| Constance Harriman |
|
Signature
|
Title
|
Date
|
||
|
/s/ General Peter Pace
|
Director
|
April 1, 2013
|
||
| General Peter Pace |
|
Signature
|
Title
|
Date
|
||
|
/s/ Paul Wolfowitz
|
Director
|
April 1, 2013
|
||
| Paul Wolfowitz |
|
Signature
|
Title
|
Date
|
||
| /s/ Jonathan Weinberger |
Director
|
April 1, 2013
|
||
| Jonathan Weinberger |
|
Signature
|
Title
|
Date
|
||
|
/s/ Claudio R. Ballard
|
Director
|
April 1, 2013
|
||
| Claudio R. Ballard |
|
Signature
|
Title
|
Date
|
||
|
/s/ Scott A. McPherson
|
Chief Financial Officer
|
April 1, 2013
|
||
| Scott A. McPherson |
|
December 31, 2012
|
December 31, 2011
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash and cash equivalents
|
$ | 2,994,350 | $ | 53,573 | ||||
|
Accounts receivable, net of allowance of $0 at
December 31, 2012 and December 31, 2011
|
3,473 | - | ||||||
|
Inventory
|
19,980 | 35,137 | ||||||
|
Deferred finance charges
|
- | 13,625 | ||||||
|
Prepaid expenses
|
750,000 | 117,760 | ||||||
|
TOTAL CURRENT ASSETS
|
3,767,803 | 220,095 | ||||||
|
PROPERTY AND EQUIPMENT
|
||||||||
|
Capital equipment
|
34,964 | 32,604 | ||||||
|
Less accumulated depreciation
|
32,624 | 32,604 | ||||||
| 2,340 | - | |||||||
|
|
||||||||
|
Patents and Trademark, net of accumulated amortization of
$92,302 and $78,851 as of December 31, 2012 and December 31, 2011
|
311,832 | 118,618 | ||||||
|
TOTAL ASSETS
|
$ | 4,081,975 | $ | 338,713 | ||||
|
LIABILITIES AND STOCKHOLDERS
’
DEFICIT
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable and accrued expenses
|
660,493 | $ | 634,632 | |||||
|
Accrued interest
|
97,563 | 8,667 | ||||||
|
Notes payable
|
200,000 | 50,000 | ||||||
|
TOTAL CURRENT LIABILITIES
|
958,056 | 693,299 | ||||||
|
LONG-TERM LIABILITIES
|
||||||||
|
Accrued interest
|
975,559 | 940,554 | ||||||
|
Senior secured convertible notes payable
|
775,249 | 781,500 | ||||||
|
Convertible notes payable
|
140,000 | 140,000 | ||||||
|
Notes payable, net of discount of $13,632 and $18,589 as of
December 31, 2012 and December 31, 2011
|
697,368 | 1,092,411 | ||||||
|
TOTAL LONG-TERM LIABILITIES
|
2,588,176 | 2,954,465 | ||||||
|
CONTINGENCIES
|
||||||||
|
STOCKHOLDERS
’
DEFICIT
|
||||||||
|
Preferred Stock, $ .001 par value; 75,000,000 shares authorized;
no shares issued and outstanding
|
- | - | ||||||
|
Common stock, $ .001 par value; 675,000,000 shares authorized;
248,244,012 shares issued and 218,448,109 outstanding at December 31, 2012 and 174,940,506 shares issued and 145,144,603 outstanding at December 31, 2011
|
248,244 | 174,940 | ||||||
|
Additional paid in capital
|
13,787,929 | 8,817,382 | ||||||
|
Treasury stock, at cost (29,795,903 shares at December 31, 2012
and December 31, 2011)
|
(113,389 | ) | (113,389 | ) | ||||
|
Deficit accumulated during the development stage
|
(13,387,041 | ) | (12,187,984 | ) | ||||
|
STOCKHOLDERS
’
DEFICIT
|
535,743 | (3,309,051 | ) | |||||
|
TOTAL LIABILITIES AND STOCKHOLDERS
’
DEFICIT
|
$ | 4,081,975 | $ | 338,713 | ||||
|
Year Ended
|
Year Ended
|
|||||||||||
|
Cumulative
|
Ended
|
Ended
|
||||||||||
|
Since
|
December 31,
|
December 31,
|
||||||||||
|
Inception
|
2012
|
2011
|
||||||||||
|
NET REVENUES
|
||||||||||||
|
Sales
|
$ | 461,155 | $ | 7,029 | $ | 900 | ||||||
|
Royalties
|
645,180 | 10,000 | 7,984 | |||||||||
|
TOTAL NET REVENUE
|
1,106,335 | 17,029 | 8,884 | |||||||||
|
COST OF SALES
|
429,031 | 4,083 | 373 | |||||||||
|
GROSS PROFIT
|
677,304 | 12,946 | 8,511 | |||||||||
|
OPERATING EXPENSES
|
||||||||||||
|
General and administrative
|
1,543,359 | 129,329 | 114,376 | |||||||||
|
Legal and Accounting
|
1,538,786 | 276,774 | 71,847 | |||||||||
|
Patent costs
|
65,000 | - | - | |||||||||
|
Payroll Expenses
|
3,412,982 | 612,721 | 227,658 | |||||||||
|
Research and development
|
867,792 | 5,420 | 9,081 | |||||||||
|
Sales and Marketing
|
5,019,732 | 66,499 | 113,377 | |||||||||
|
Total operating expenses
|
12,447,651 | 1,090,743 | 536,339 | |||||||||
|
LOSS BEFORE OTHER INCOME
|
(11,770,347 | ) | (1,077,797 | ) | (527,828 | ) | ||||||
|
OTHER INCOME (EXPENSE)
|
||||||||||||
|
Interest income
|
63,664 | 1 | 59 | |||||||||
|
Interest expense
|
(2,190,432 | ) | (277,371 | ) | (321,586 | ) | ||||||
|
Gain on debt forgiveness
|
340,352 | 156,110 | 184,242 | |||||||||
|
Gain on disposition of assets
|
4,722 | - | - | |||||||||
| (1,781,694 | ) | (121,260 | ) | (137,285 | ) | |||||||
|
LOSS BEFORE INCOME TAX BENEFIT
|
(13,552,041 | ) | (1,199,057 | ) | (665,113 | ) | ||||||
|
INCOME TAX BENEFIT
|
(165,000 | ) | - | - | ||||||||
|
NET LOSS
|
$ | (13,387,041 | ) | $ | (1,199,057 | ) | $ | (665,113 | ) | |||
|
BASIC AND DILUTED NET LOSS PER
COMMON SHARE
|
$ | (0.01 | ) | $ | (0.00 | ) | ||||||
|
BASIC AND DILUTED WEIGHTED AVERAGE
COMMON SHARES OUTSTANDING
|
150,559,287 | 146,076,571 | ||||||||||
|
Deficit
|
||||||||||||||||||||||||||||
|
Common
|
Accumulated
|
|||||||||||||||||||||||||||
|
Stock
|
Deferred
|
Additional
|
During the
|
|||||||||||||||||||||||||
|
Number of
|
Consulting
|
Paid-In
|
Treasury
|
Development
|
||||||||||||||||||||||||
|
Shares
|
Amount
|
Fees
|
Capital
|
Stock
|
Stage
|
Total
|
||||||||||||||||||||||
|
Issuance of initial 4,278,000 shares on November 10, 1999
|
4,278,000 | $ | 4,278 | $ | - | $ | 16,595 | $ | - | $ | - | $ | 20,873 | |||||||||||||||
|
Issuance of shares of common stock in exchange for services
|
1,232,000 | 1,232 | - | 35,728 | - | - | 36,960 | |||||||||||||||||||||
|
Issuance of shares of common stock
|
2,090,000 | 2,090 | - | 60,610 | - | - | 62,700 | |||||||||||||||||||||
|
Stock issuance costs
|
- | - | - | (13,690 | ) | - | - | (13,690 | ) | |||||||||||||||||||
|
Net loss
|
- | - | - | - | - | (54,113 | ) | (54,113 | ) | |||||||||||||||||||
|
Balance, December 31, 1999
|
7,600,000 | 7,600 | - | 99,243 | - | (54,113 | ) | 52,730 | ||||||||||||||||||||
|
Issuance of shares of common stock
|
5,449,999 | 5,450 | - | 921,050 | - | - | 926,500 | |||||||||||||||||||||
|
Issuance of shares of common stock in exchange for services
|
240,000 | 240 | (40,800 | ) | 40,560 | - | - | - | ||||||||||||||||||||
|
Stock issuance costs
|
- | - | - | (16,335 | ) | - | - | (16,335 | ) | |||||||||||||||||||
|
Fair value of non-employee stock options grants
|
- | - | - | 50,350 | - | - | 50,350 | |||||||||||||||||||||
|
Amortization of deferred consulting fees
|
- | - | 20,117 | - | - | - | 20,117 | |||||||||||||||||||||
|
Net loss
|
- | - | - | - | - | (367,829 | ) | (367,829 | ) | |||||||||||||||||||
|
Balance, December 31, 2000
|
13,289,999 | 13,290 | (20,683 | ) | 1,094,868 | - | (421,942 | ) | 665,533 | |||||||||||||||||||
|
Issuance of shares of common stock
|
217,500 | 218 | - | 77,723 | - | - | 77,941 | |||||||||||||||||||||
|
Issuance of shares of common stock and stock options for
acquisition of subsidiary
|
2,000,000 | 2,000 | - | 736,000 | - | - | 738,000 | |||||||||||||||||||||
|
Issuance of stock options
|
- | - | - | 15,000 | - | - | 15,000 | |||||||||||||||||||||
|
Exercise of options
|
1,450,368 | 1,450 | - | 230,609 | - | - | 232,059 | |||||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 323,250 | - | - | 323,250 | |||||||||||||||||||||
|
Amortization of deferred consulting fees
|
- | - | 20,683 | - | - | - | 20,683 | |||||||||||||||||||||
|
Net loss
|
- | - | - | - | - | (1,052,299 | ) | (1,052,299 | ) | |||||||||||||||||||
|
Balance, December 31, 2001
|
16,957,867 | 16,958 | - | 2,477,450 | - | (1,474,241 | ) | 1,020,167 | ||||||||||||||||||||
|
Deficit
|
||||||||||||||||||||||||||||
|
Common
|
Accumulated
|
|||||||||||||||||||||||||||
|
Stock
|
Deferred
|
Additional
|
During the
|
|||||||||||||||||||||||||
|
Number of
|
Consulting
|
Paid-In
|
Treasury
|
Development
|
||||||||||||||||||||||||
|
Shares
|
Amount
|
Fees
|
Capital
|
Stock
|
Stage
|
Total
|
||||||||||||||||||||||
|
Issuance of shares of common stock
|
3,376,875 | 3,377 | - | 687,223 | - | - | 690,600 | |||||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 94,000 | - | - | 94,000 | |||||||||||||||||||||
|
Salary due to shareholder contributed capital
|
- | - | - | 15,000 | - | - | 15,000 | |||||||||||||||||||||
|
Return of shares of common stock related to purchase price
adjustment
|
(1,000,000 | ) | (1,000 | ) | - | (353,000 | ) | - | - | (354,000 | ) | |||||||||||||||||
|
Net loss
|
- | - | - | - | - | (1,195,753 | ) | (1,195,753 | ) | |||||||||||||||||||
|
Balance, December 31, 2002
|
19,334,742 | 19,335 | - | 2,920,673 | - | (2,669,994 | ) | 270,014 | ||||||||||||||||||||
|
Issuance of shares of common stock
|
22,512,764 | 22,512 | - | 1,387,109 | - | - | 1,409,621 | |||||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 213,300 | - | - | 213,300 | |||||||||||||||||||||
|
Issuance of shares of common stock in exchange for services
|
143,000 | 143 | - | 23,857 | - | - | 24,000 | |||||||||||||||||||||
|
Stock issuance costs
|
- | - | - | (49,735 | ) | - | - | (49,735 | ) | |||||||||||||||||||
|
Net loss
|
- | - | - | - | - | (1,107,120 | ) | (1,107,120 | ) | |||||||||||||||||||
|
Balance, December 31, 2003
|
41,990,506 | 41,990 | - | 4,495,204 | - | (3,777,114 | ) | 760,080 | ||||||||||||||||||||
|
Stock issuance costs
|
- | - | - | (25,000 | ) | - | - | (25,000 | ) | |||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 493,600 | - | - | 493,600 | |||||||||||||||||||||
|
Issuance of shares of common stock
|
18,600,000 | 18,600 | - | 939,881 | - | - | 958,481 | |||||||||||||||||||||
|
Net loss
|
- | - | - | - | - | (1,406,506 | ) | (1,406,506 | ) | |||||||||||||||||||
|
Balance, December 31, 2004
|
60,590,506 | 60,590 | - | 5,903,685 | - | (5,183,620 | ) | 780,655 | ||||||||||||||||||||
|
Deficit
|
||||||||||||||||||||||||||||
|
Common
|
Accumulated
|
|||||||||||||||||||||||||||
|
Stock
|
Deferred
|
Additional
|
During the
|
|||||||||||||||||||||||||
|
Number of
|
Consulting
|
Paid-In
|
Treasury
|
Development
|
||||||||||||||||||||||||
|
Shares
|
Amount
|
Fees
|
Capital
|
Stock
|
Stage
|
Total
|
||||||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 286,762 | - | - | 286,762 | |||||||||||||||||||||
|
Issuance of shares of common stock
|
3,000,000 | 3,000 | - | 102,000 | - | - | 105,000 | |||||||||||||||||||||
|
Net loss for the year ended December 31, 2005
|
- | - | - | - | - | (1,266,811 | ) | (1,266,811 | ) | |||||||||||||||||||
|
Balance at December 31, 2005
|
63,590,506 | 63,590 | - | 6,292,447 | - | (6,450,431 | ) | (94,394 | ) | |||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 215,463 | - | - | 215,463 | |||||||||||||||||||||
|
Fair value of employee stock options
|
- | - | - | 135,098 | - | - | 135,098 | |||||||||||||||||||||
|
Fair value of warrants issued for deferred finance charges
|
- | - | - | 392,376 | - | - | 392,376 | |||||||||||||||||||||
|
Exercise of warrants
|
5,550,000 | 5,550 | - | 49,950 | - | - | 55,500 | |||||||||||||||||||||
|
Exercise of options
|
4,300,000 | 4,300 | - | (3,870 | ) | - | - | 430 | ||||||||||||||||||||
|
Shares retired upon cancellation of consulting agreements
|
(1,200,000 | ) | (1,200 | ) | - | 1,080 | - | - | (120 | ) | ||||||||||||||||||
|
Issuance of shares for services
|
1,200,000 | 1,200 | - | 53,800 | - | - | 55,000 | |||||||||||||||||||||
|
Net loss for the year ended December 31, 2006
|
- | - | - | - | - | (1,607,017 | ) | (1,607,017 | ) | |||||||||||||||||||
|
Balance at December 31, 2006
|
73,440,506 | 73,440 | - | 7,136,344 | - | (8,057,448 | ) | (847,664 | ) | |||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - |
47,692
|
- | - |
47,692
|
|||||||||||||||||||||
|
Fair value of employee stock options
|
- | - | - | 67,651 | - | - | 67,651 | |||||||||||||||||||||
|
Recognition of beneficial conversion feature
|
- | - | - | 375,000 | - | - | 375,000 | |||||||||||||||||||||
|
Net loss for the year ended December 31, 2007
|
- | - | - | - | - | (1,117,334 | ) | (1,117,334 | ) | |||||||||||||||||||
|
Balance at December 31, 2007
|
73,440,506 | 73,440 | - | 7,626,687 | - | (9,174,782 | ) | (1,474,655 | ) | |||||||||||||||||||
|
Deficit
|
||||||||||||||||||||||||||||
|
Common
|
Accumulated
|
|||||||||||||||||||||||||||
|
Stock
|
Deferred
|
Additional
|
During the
|
|||||||||||||||||||||||||
|
Number of
|
Consulting
|
Paid-In
|
Treasury
|
Development
|
||||||||||||||||||||||||
|
Shares
|
Amount
|
Fees
|
Capital
|
Stock
|
Stage
|
Total
|
||||||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 28,752 | - | - | 28,752 | |||||||||||||||||||||
|
Fair value of employee stock options
|
- | - | - | 19,720 | - | - | 19,720 | |||||||||||||||||||||
|
Fair value of warrants issued in conjunction with debt financing
|
- | - | - | 25,000 | - | - | 25,000 | |||||||||||||||||||||
|
Net loss for the year ended December 31, 2008
|
- | - | - | - | - | (931,338 | ) | (931,338 | ) | |||||||||||||||||||
|
Balance at December 31, 2008
|
73,440,506 | 73,440 | - | 7,700,159 | - | (10,106,120 | ) | (2,332,521 | ) | |||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 1,524 | - | - | 1,524 | |||||||||||||||||||||
|
Fair value of warrants issued in conjunction with debt financing
|
- | - | - | 15,450 | - | - | 15,450 | |||||||||||||||||||||
|
Issuance of shares for services
|
7,200,000 | 7,200 | - | 40,500 | - | - | 47,700 | |||||||||||||||||||||
|
Shares issued for conversion of notes payable
|
48,750,000 | 48,750 | - | 263,291 | - | - | 312,041 | |||||||||||||||||||||
|
Net loss for the year ended December 31, 2009
|
- | - | - | - | - | (694,910 | ) | (694,910 | ) | |||||||||||||||||||
|
Balance at December 31, 2009
|
129,390,506 | 129,390 | - | 8,020,924 | - | (10,801,030 | ) | (2,650,716 | ) | |||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 364 | - | - | 364 | |||||||||||||||||||||
|
Fair value of warrants issued in conjunction with debt financing
|
- | - | - | 20,143 | - | - | 20,143 | |||||||||||||||||||||
|
Issuance of shares for services
|
25,950,000 | 25,950 | - | 182,650 | - | - | 208,600 | |||||||||||||||||||||
|
Net loss for the year ended December 31, 2010
|
- | - | - | - | - | (721,841 | ) | (721,841 | ) | |||||||||||||||||||
|
Balance at December 31, 2010
|
155,340,506 | 155,340 | - | 8,224,081 | - | (11,522,871 | ) | (3,143,450 | ) | |||||||||||||||||||
|
Deficit
|
||||||||||||||||||||||||||||
|
Common
|
Accumulated
|
|||||||||||||||||||||||||||
|
Stock
|
Deferred
|
Additional
|
During the
|
|||||||||||||||||||||||||
|
Number of
|
Consulting
|
Paid-In
|
Treasury
|
Development
|
||||||||||||||||||||||||
|
Shares
|
Amount
|
Fees
|
Capital
|
Stock
|
Stage
|
Total
|
||||||||||||||||||||||
|
Issuance of shares for services
|
1,000,000 | 1,000 | - | 29,000 | - | - | 30,000 | |||||||||||||||||||||
|
Contribution of common stock from related parties
|
(12,000,000 | ) | - | - | 95,594 | (95,594 | ) | - | - | |||||||||||||||||||
|
Purchase of common stock for treasury
|
(17,795,903 | ) | - | - | - | (17,795 | ) | - | (17,795 | ) | ||||||||||||||||||
|
Sale of common stock
|
15,500,000 | 15,500 | - | 384,500 | - | - | 400,000 | |||||||||||||||||||||
|
Issuance of shares for stock issuance costs
|
2,100,000 | 2,100 | - | (2,100 | ) | - | - | - | ||||||||||||||||||||
|
Stock issuance costs
|
- | - | - | (40,000 | ) | - | - | (40,000 | ) | |||||||||||||||||||
|
Exercise of options
|
1,000,000 | 1,000 | - | 9,000 | - | - | 10,000 | |||||||||||||||||||||
|
Fair value of warrants issued in conjunction with debt financing
|
- | - | - | 21,275 | - | - | 21,275 | |||||||||||||||||||||
|
Fair value of employee stock options
|
- | - | - | 47,658 | - | - | 47,658 | |||||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 48,374 | - | - | 48,374 | |||||||||||||||||||||
|
Net loss for the year ended December 31, 2011
|
- | - | - | - | - | (665,113 | ) | (665,113 | ) | |||||||||||||||||||
|
Balance at December 31, 2011
|
145,144,603 | 174,940 | - | 8,817,382 | (113,389 | ) | (12,187,984 | ) | (3,309,051 | ) | ||||||||||||||||||
|
Issuance of shares for services
|
1,000,000 | 1,000 | - | 45,500 | - | - | 46,500 | |||||||||||||||||||||
|
Issuance of shares of common stock
|
44,111,111 | 44,111 | - | 2,015,889 | - | - | 2,060,000 | |||||||||||||||||||||
|
Issuance of stock for licensing
|
2,222,222 | 2,222 | - | 97,778 | - | - | 100,000 | |||||||||||||||||||||
|
Issuance of warrants for licensing
|
- | - | - | 100,000 | - | - | 100,000 | |||||||||||||||||||||
|
Issuance of stock for trademarks, etc.
|
2,222,222 | 2,222 | - | 97,778 | - | - | 100,000 | |||||||||||||||||||||
|
Issuance of warrants for trademarks, etc.
|
- | - | - | 100,000 | - | - | 100,000 | |||||||||||||||||||||
|
Shares issued for conversion of notes payable and accrued interest
|
12,923,622 | 12,925 | - | 568,639 | - | - | 581,564 | |||||||||||||||||||||
|
Issuance of warrants for technology services agreement
|
- | - | - | 1,200,000 | - | - | 1,200,000 | |||||||||||||||||||||
|
Exercise of options
|
10,490,996 | 10,491 | - | 2,622 | - | - | 13,113 | |||||||||||||||||||||
|
Exercise of warrants
|
333,333 | 333 | - | 49,667 | - | - | 50,000 | |||||||||||||||||||||
|
Fair value of employee stock options
|
- | - | - | 332,036 | - | - | 332,036 | |||||||||||||||||||||
|
Fair value of non-employee stock options
|
- | - | - | 11,638 | - | - | 11,638 | |||||||||||||||||||||
| Forgiveness of debt-related party | - | - | - | 349,000 | - | - | 349,000 | |||||||||||||||||||||
|
Net loss for the year ended December 31, 2012
|
- | - | - | - | - | (1,199,057 | ) | (1,199,057 | ) | |||||||||||||||||||
|
Balance at December 31, 2012
|
218,448,109 | $ | 248,244 | $ | - | $ | 13,787,929 | $ | (113,389 | ) | $ | (13,387,041 | ) | $ | 535,743 | |||||||||||||
|
Year
|
Year
|
|||||||||||
|
Cumulative
|
Ended
|
Ended
|
||||||||||
|
Since
|
December 31,
|
December 31,
|
||||||||||
|
Inception
|
2012
|
2011
|
||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||||||
|
Net loss
|
(13,387,041 | ) | (1,199,057 | ) | (665,113 | ) | ||||||
|
Adjustments to reconcile net loss to net cash used in
operating activities
|
||||||||||||
|
Fair value of options issued in exchange for services
|
2,417,232 | 343,674 | 96,032 | |||||||||
|
Accretion of interest on deferred finance charges
|
453,625 | 13,625 | 27,149 | |||||||||
|
Accretion of discount on notes payable
|
443,236 | 4,957 | 17,416 | |||||||||
|
Salary due to stockholder contributed to capital
|
15,000 | - | - | |||||||||
|
Amortization and depreciation
|
530,055 | 13,471 | 10,904 | |||||||||
|
Gain on disposition of assets
|
(4,722 | ) | - | - | ||||||||
|
Gain on debt forgiveness
|
(340,352 | ) | (156,110 | ) | (184,242 | ) | ||||||
|
Stock issued in exchange for services
|
553,760 | 46,500 | 30,000 | |||||||||
|
Financing expenses paid directly from stock proceeds
|
5,270 | - | - | |||||||||
|
Amortization of deferred consulting fees
|
40,800 | - | - | |||||||||
|
(Increase) decrease in assets
|
||||||||||||
|
Accounts receivable
|
(3,473 | ) | (3,473 | ) | 10,193 | |||||||
|
Inventory
|
19,980 | 15,157 | (11,451 | ) | ||||||||
|
Prepaid expenses
|
(350,000 | ) | (232,240 | ) | 21,936 | |||||||
|
Increase in liabilities
|
||||||||||||
|
Accounts payable and accrued expenses
|
2,567,362 | 786,436 | 333,291 | |||||||||
|
Net cash used in operating activities
|
$ | (7,039,268 | ) | $ | (367,060 | ) | $ | (313,885 | ) | |||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||||||
|
Purchase of property and equipment
|
(38,109 | ) | (2,360 | ) | - | |||||||
|
Purchase of intangibles
|
(224,134 | ) | (6,665 | ) | (3,577 | ) | ||||||
|
Proceeds from sale of assets
|
6,738 | - | - | |||||||||
|
Net cash used in investing activities
|
(255,505 | ) | (9,025 | ) | (3,577 | ) | ||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
|
Proceeds from issuance of common stock
|
6,551,447 | 2,060,000 | 400,000 | |||||||||
|
Proceeds from exercise of stock options
|
255,482 | 13,113 | 10,000 | |||||||||
|
Proceeds issuance of stock options
|
15,000 | - | - | |||||||||
|
Proceeds from exercise of warrants
|
105,500 | 50,000 | - | |||||||||
|
Proceeds from issuance of warrants
|
1,000,000 | 1,000,000 | - | |||||||||
|
Proceeds from issuance of notes payable
|
2,789,000 | 200,000 | - | |||||||||
|
Repayments of notes payable
|
(202,751 | ) | (6,251 | ) | (58,500 | ) | ||||||
|
Payment for treasury stock
|
(17,795 | ) | - | (17,795 | ) | |||||||
|
Debt issuance costs
|
(62,000 | ) | - | - | ||||||||
|
Stock issuance costs
|
(144,760 | ) | - | (40,000 | ) | |||||||
|
Net cash provided by financing activities
|
10,289,123 | 3,316,862 | 293,705 | |||||||||
|
NET DECREASE IN CASH AND
CASH EQUIVALENTS
|
2,994,350 | 2,940,777 | (23,757 | ) | ||||||||
|
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
|
- | 53,573 | 77,330 | |||||||||
|
CASH AND CASH EQUIVALENTS - END OF PERIOD
|
$ | 2,994,350 | $ | 2,994,350 | $ | 53,573 | ||||||
|
SUPPLEMENTAL DISCLOSURE OF NON-CASH
INVESTING AND FINANCING ACTIVITIES:
|
||||||||||||
|
Cash paid during the year for:
|
||||||||||||
|
Interest
|
$ | 39,440 | $ | - | $ | 6,557 | ||||||
|
Income taxes
|
$ | - | $ | - | $ | - | ||||||
|
Return of shares of common stock related to
purchase price adjustment
|
||||||||||||
|
Common stock
|
(1,000 | ) | - | - | ||||||||
|
Additional paid-in capital
|
(353,000 | ) | - | - | ||||||||
|
Intangible assets
|
$ | (354,000 | ) | $ | - | $ | - | |||||
|
Issuance of common stock and stock options
for acquisition of subsidiary
|
$ | 738,000 | $ | - | $ | - | ||||||
|
Proceeds from common stock sales applied directly
to debt and financing expenses repayment
|
$ | 55,270 | $ | - | $ | - | ||||||
|
Fair value of warrants issued for deferred finance charges
|
$ | 392,376 | $ | - | $ | - | ||||||
|
Fair value of stock issued for conversion of notes payable
and accrued interest
|
$ | 893,605 | $ | 581,564 | $ | - | ||||||
|
Fair value of stock issued for purchase of assets
|
$ | 100,000 | $ | 100,000 | $ | - | ||||||
|
Fair value of warrants issued for purchase of assets
|
$ | 100,000 | $ | 100,000 | $ | - | ||||||
|
Fair value of stock issued for licensing costs
|
$ | 100,000 | $ | 100,000 | $ | - | ||||||
|
Fair value of warrants issued for licensing costs
|
$ | 300,000 | $ | 300,000 | $ | - | ||||||
|
Fair value of beneficial conversion option
|
$ | 400,000 | $ | - | $ | - | ||||||
|
Fair value of warrants issued as debt discount
|
$ | 78,043 | $ | - | $ | 21,275 | ||||||
|
Issuance of common stock for stock issuance costs
|
$ | 2,100 | $ | - | $ | 2,100 | ||||||
|
Issuance of options as stock cost for treasury stock
|
$ | 5,594 | $ | - | $ | 5,594 | ||||||
| Forgiveness of debt-related party treated as additional paid in capital | $ | 349,000 | $ | 349,000 | $ | - | ||||||
|
|
1.
|
Those that clarify the Board’s intent about the application of existing fair value measurement and disclosure requirements.
|
|
|
2.
|
Those that change a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements.
|
|
Year Ended
December 31,
2012
|
Year Ended
December 31,
2011
|
|||||||
|
Current
|
$ | 490,000 | $ | 142,000 | ||||
|
Deferred
|
263,000 | 97,000 | ||||||
|
Change in valuation allowance
|
(753,000 | ) | (239,000 | ) | ||||
| $ | - | $ | - | |||||
|
2012
|
2011
|
|||||||||||||||
|
Amount
|
%
|
Amount
|
%
|
|||||||||||||
|
U.S federal income tax benefit at
Federal statutory rate |
$ | (298,000 | ) | (35 | ) | $ | (226,000 | ) | (34 | ) | ||||||
|
State tax, net of federal tax effect
|
(50,000 | ) | (6 | ) | (38,000 | ) | (6 | ) | ||||||||
|
Non deductible accrued expenses
|
(238,000 | ) | (28 | ) | - | - | ||||||||||
|
Non deductible share based compensation
|
(167,000 | ) | (20 | ) | 25,000 | 4 | ||||||||||
|
Change in valuation allowance
|
753,000 | 89 | 239,000 | 36 | ||||||||||||
| $ | - | - | $ | - | - | |||||||||||
|
December 31,
2012
|
December 31,
2011
|
|||||||
|
Deferred tax asset for NOL carryforwards
|
$ | 3,308,000 | $ | 2,354,000 | ||||
|
Deferred tax liability for intangibles
|
(165,000 | ) | (165,000 | ) | ||||
|
Non taxable income
|
162,000 | 47,000 | ||||||
|
(Deductible) non deductible accrued expenses
|
386,000 | 702,000 | ||||||
|
Valuation allowance
|
(3,691,000 | ) | (2,938,000 | ) | ||||
| $ | - | $ | - | |||||
|
December 31, 2012
|
December 31, 2011
|
|||||||
|
Unsecured notes payable; interest at 10% per annum; principal and accrued interest due at maturity in September 2015
|
$ | 561,000 | $ | 561,000 | ||||
|
Series A notes payable; interest at 8% per annum; principal and accrued interest due at extended maturity date in September 2015
|
150,000 | 150,000 | ||||||
|
Series A notes payable; interest at 8% per annum; principal and accrued interest due at maturity in October 2011 (past due)
|
50,000 | 50,000 | ||||||
|
Notes payable, interest at 25% per annum; principal and interest due September 2013
|
150,000 | 400,000 | ||||||
|
Less: Debt discount
|
(13,632 | ) | (18,589 | ) | ||||
| 897,368 | 1,142,411 | |||||||
|
Less: Current portion
|
200,000 | 50,000 | ||||||
|
Long-term portion
|
$ | 697,368 | $ | 1,092,411 | ||||
|
a.
|
First monies realized by the Company from its share of the net proceeds of the lawsuit shall be allocated and paid to the lender until the principal and base interest accruing has been fully paid.
|
|
b.
|
The next monies from the net proceeds of the litigation settlement will be paid to the Company to reimburse for out-of-pocket legal costs related to the lawsuit.
|
|
c.
|
The next $825,000 of proceeds will be split 50%/50% between the Company and the lenders.
|
|
d.
|
The next $1 million realized by the Company shall be allocated 90% to the Company and 10% to the lenders.
|
|
e.
|
The next $1 million realized by Company shall be allocated 85% to Company and 15% to lenders.
|
|
f.
|
All remaining proceeds realized by Company shall be allocated 80% to Company and 20% to lenders.
|
|
(a)
|
$450,000 on the date of the agreement (December 31, 2012), consisting of $250,000 in cash and warrants to purchase 4,444,444 shares of Common Stock under a cashless exercise initially at an exercise price of $0.045 on the terms set forth under the warrants issued by the Company to Zaah under the warrant, dated as of December 31, 2012. The $450,000 is reflected as prepaid expenses on the December 31, 2012 balance sheet.
|
|
(b)
|
$100,000, accrued in full as of the date of this Agreement, and reflected as prepaid expenses on the December 31, 2012 balance sheet, but payable in twelve (12) months from the date hereof to a designee of Zaah
’
s selection, with a right to convert (at Zaah
’s
sole discretion, from time to time at any time) to shares of common stock at the prevailing market price per share of common stock (which, as long as the common stock is listed, shall be the closing price on the last trading day prior to such issuance or sale of the common stock as traded on a national securities exchange, the NASDAQ Global Market, the NASDAQ Capital Market, or another nationally recognized trading system (including Pink OTC Markets, Inc.)); and
|
|
(c)
|
a commission of 10% of the revenue generated by any Company transaction originated through the efforts of Zaah, as substantiated by a written agreement between the Company and Zaah, specifically referencing the transaction in which Zaah is entitled to such commission, payable by the Company to Zaah in cash. Such payment shall be made on the earlier of (i) the date of the signing of such transaction, (ii) the date of the closing of the transaction, or (iii) any date on which any funds are paid to the Company in respect of such transaction.
|
|
(a)
|
Payment 1, payable upon execution of the Agreement on December 31, 2012: The sum of One Hundred Thousand Dollars ($100,000), to be paid by issuing (i) a number of shares of Common Stock, par value $.001 per shares (“Shares”), of the Company equal to (x) $100,000 divided by (y) $0.045 (2,222,222 shares) and (ii) cashless exercise warrants to purchase an equal number of Shares exercisable at a price of Ten Cents ($0.10) per Share with a term of five (5) years. The fair value of the shares of common stock ($100,000) and the fair value of the cashless exercise warrants ($100,000) are reflected as prepaid expenses on the December 31, 2012 balance sheet.
|
|
(b)
|
Payment 2, payable on January 1, 2014: The sum of Four Hundred Thousand Dollars ($400,000), to be paid by issuing (i) a number of Shares equal to (x) $400,000 divided by (y) a price which equals a 10% discount to market and (ii) cashless exercise warrants to purchase an equal number of Shares exercisable at a price of Ten Cents ($0.10) per Share with a term of five (5) years.
|
|
(c)
|
Payment 3, payable on January 1, 2015: The sum of Four Million Five Hundred Thousand Dollars ($4,500,000), to be paid by issuing (i) a number of Shares equal to (x) $4,500,000 divided by (y) a price which equals a 10% discount to market and (ii) cashless exercise warrants to purchase an equal number of Shares exercisable at a price of Ten Cents ($0.10) per Share with a term of five (5) years.
|
|
(d)
|
Future Payments Contingent: the Company’s payment of Payment 2 and Payment 3 is contingent. To the extent that VerifyMe does not develop and license to the Company, at a time subsequent to Payment 1, further technology and/or a further patent right related to the local, mobile and cloud based biometric security systems, then any payments not already paid, will not longer by due to VerifyMe, this nonperformance being a likelihood, more likely than not.
|
|
Option/Warrant
Shares
|
Exercise
Price
|
Weighted Average
Exercise
Price
|
||||||||||
|
Outstanding, December 31, 2010
|
19,856,662 | $0.01 to $0.20 | $ | 0.02 | ||||||||
|
Granted
|
7,235,996 | 0.00125 | - | |||||||||
|
Exercised
|
(1,000,000 | ) | 0.01 | - | ||||||||
|
Expired/Returned
|
(10,506,662 | ) |
0.01 to 0.03
|
(0.01 | ) | |||||||
|
Outstanding, December 31, 2011
|
15,585,996 | $0.00125 to $0.20 | $ | 0.01 | ||||||||
|
Granted
|
72,422,221 |
0.05 to 0.10
|
0.08 | |||||||||
|
Transferred to employee options
|
(200,000 | ) | (0.05 | ) | - | |||||||
|
Exercised
|
(5,000,996 | ) | 0.00125 | - | ||||||||
|
Expired
|
- | - | - | |||||||||
|
Outstanding, December 31, 2012
|
82,807,221 | $.00125 to $.20 | $ | 0.09 | ||||||||
|
Exercisable, December 31, 2012
|
82,807,221 | $.00125 to $.20 | $ | 0.09 | ||||||||
|
Weighted Average Remaining Life,
Exercisable, December 31, 2012 (years) |
6.4 | |||||||||||
|
Option/Warrant
Shares
|
Exercise
Price
|
Weighted Average
Exercise
Price
|
||||||||||
|
Outstanding, December 31, 2010
|
7,100,000 | $.01 to $.28 | $ | 0.07 | ||||||||
|
Granted
|
6,390,000 | $0.00125 | $ | 0.00125 | ||||||||
|
Exercised
|
- | - | - | |||||||||
|
Expired/Returned
|
(7,100,000 | ) | $.01 - $.03 | (0.07 | ) | |||||||
|
Outstanding, December 31, 2011
|
6,390,000 | $0.00125 | $ | 0.00125 | ||||||||
|
Granted
|
15,000,000 | 0.05 - 0.15 | 0.06 | |||||||||
|
Transferred from non-employee options
|
200,000 | 0.05 | - | |||||||||
|
Exercised
|
(5,823,333 | ) | 0.00125 - 0.15 | - | ||||||||
|
Expired/Returned
|
- | - | - | |||||||||
|
Outstanding, December 31, 2012
|
15,766,667 | $0.00125 to $0.10 | $ | 0.06 | ||||||||
|
Exercisable, December 31, 2012
|
10,766,667 | $0.00125 to $0.10 | $ | 0.07 | ||||||||
|
Weighted Average Remaining Life,
Exercisable, December 31, 2012 (years) |
9.8 | |||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|